September 2017: We revised the guideline throughout to link to other NICE guidance (including technology appraisals) and some relevant non-NICE guidelines, as well as including new MHRA safety advice and updated licensing information.
Minor updates since publication
October 2021: We added links to HIV in Europe's HIV indicator conditions and our guideline on HIV testing to section 1.2 on assessment and referral. See the surveillance report on HIV indicator conditions for more information.
August 2019: Links to the MHRA safety advice on the risk of using retinoids in pregnancy have been updated to the June 2019 version. Links also updated throughout to the Dermatology Life Quality Index pages at Cardiff University's website.